Industry Roundtable Members Add Significant Value to the Annual Meeting Experience The AAN has long recognized the value of collaborating with industry, and the Industry Roundtable (IRT) is the AAN’s corporate membership program for companies wishing to deepen their relationship with the Academy to share vision, intellect, and financial resources in the mutual pursuit of improved quality of patient care.
$50,000 Members:
While the IRT is active year-round, member companies are particularly engaged at the AAN Annual Meeting, working jointly with the Academy to improve the Annual Meeting experience for all attendees through the valuable support of continuing medical education courses, in-kind donations for workshops, contribution of high-quality research to the Scientific Program, sponsorship of the Run/Walk for Brain Research, and investment in the future of neurology by supporting the AAN Leadership Programs. Thank you to the following 2022 Industry Roundtable Members*
SK Life Science
AbbVie, Inc.
Supernus Pharmaceuticals, Inc.
Acadia Pharmaceuticals, Inc.
Teva
Alexion Pharmaceuticals, Inc.
TG Therapeutics
$40,000 Members:
Allergan, an AbbVie Company Amgen
Harmony Biosciences
argenx
Horizon Therapeutics
Biogen
Medtronic
Biohaven Pharmaceuticals
Zogenix, Inc.
$25,000 Members:
Bristol Myers Squibb Eisai Inc.
Adamas Pharmaceuticals, Inc.
Eli Lilly & Company
Alnylam Pharmaceuticals, Inc.
EMD Serono, Inc.
Amneal Specialty, a division of
Amneal Pharmaceuticals LLC
Genentech, a Member of the
Roche Group
Avanir Pharmaceuticals
Ionis Pharmaceuticals
Axsome Therapeutics
Janssen Neuroscience
Impel NeuroPharma
Jazz Pharmaceuticals
UCB, Inc.
Lundbeck
$10,000 Members:
Neurocrine Biosciences
Avion Pharmaceuticals
Novartis Gene Therapies
Idorsia Pharmaceuticals
Novartis Pharmaceuticals Sanofi
0 HSCI-P000627 IDO AAN Congress (new) half-page ad CMYK 06 PRINTREADY.pdf
Sarepta Therapeutics
1
17/03/2022
Illumina 10:30
*As of February 11, 2022
Industry Therapeutic Update from Idorsia Pharmaceuticals A Panel Discussion on the Nights and Days of Insomnia
Come see us at Booth 1805 for exciting information about sleep
On behalf of Idorsia Pharmaceuticals, we are pleased to invite you to a dinner program on insomnia with the following faculty:
Alon Y. Avidan, MD, MPH, FAAN, FAASM
Paul Doghramji, MD, FAAFP
Director, UCLA Sleep Disorders Center Professor, UCLA Department of Neurology Los Angeles, CA
Senior Family Physician Collegeville Family Practice Collegeville, PA
Ashgan Elshinawy, DO
Rachel Marie E. Salas, MD, Med, FAAN
Pulmonary and Sleep Specialist Pulmonary & Sleep Disorders of NJ Plainsboro, NJ
Assistant Medical Director Johns Hopkins Center for Sleep and Wellness Baltimore, MD
This event is being held during the 2022 American Academy of Neurology Annual Meeting at the following dates and locations:
Saturday, April 2, 2022
Monday, April 4, 2022
7:00 PM - 10:00 PM
7:00 PM - 10:00 PM
Sheraton Grand Seattle Grand Ballroom CD
Grand Hyatt Seattle Leonesa Ballroom I
Please note, this event is not a CME program nor will CME credits be given for attendance. This event is not a part of the official AAN Annual Meeting programming. © 2022 Idorsia Pharmaceuticals, Ltd. US-IDS-00322 2/22
